Vycor Medical (VYCO) Revenue (2010 - 2026)
Vycor Medical (VYCO) reported Revenue of $458540.0 for Q1 2026, up 5.08% year-over-year from $436378.0 in Q1 2025, and up 9.99% on a QoQ basis from $416877.0 in Q4 2025.
Vycor Medical (VYCO) has 17 years of Revenue data on file, last reported at $458540.0 in Q1 2026.
- Quarterly Revenue rose 5.08% year-over-year to $458540.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 11.66% YoY) and the FY2025 annual result came in at $1.9 million, up 17.24% from the prior year.
- Revenue advanced to $458540.0 in Q1 2026 per VYCO's latest filing, from $416877.0 in the prior quarter.
- Across five years, Revenue topped out at $513792.0 in Q3 2025 and bottomed at $271264.0 in Q4 2022.
- The 5-year median for Revenue is $390852.0 (2024), against an average of $387932.8.
- The widest annual swing landed in 2022, when Revenue plunged 33.27%; it then surged 47.68% in 2024.
- Tracing VYCO's Revenue over 5 years: stood at $271264.0 in 2022, then rose by 13.63% to $308249.0 in 2023, then surged by 47.68% to $455226.0 in 2024, then decreased by 8.42% to $416877.0 in 2025, then gained by 9.99% to $458540.0 in 2026.
- Per Business Quant, the three latest VYCO Revenue figures stand at $458540.0 (Q1 2026), $416877.0 (Q4 2025), and $513792.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.02 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.57 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.19 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.59 Bn |
| 10 | Vycor Medical | - | - | 375,153.00 | 458,540.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458,540.00 |
| Dec 31, 2025 | 416,877.00 |
| Sep 30, 2025 | 513,792.00 |
| Jun 30, 2025 | 496,353.00 |
| Mar 31, 2025 | 436,378.00 |
| Dec 31, 2024 | 455,226.00 |
| Sep 30, 2024 | 390,852.00 |
| Jun 30, 2024 | 406,278.00 |
| Mar 31, 2024 | 336,968.00 |
| Dec 31, 2023 | 308,249.00 |
| Sep 30, 2023 | 308,593.00 |
| Jun 30, 2023 | 482,768.00 |
| Mar 31, 2023 | 360,994.00 |
| Dec 31, 2022 | 271,264.00 |
| Sep 30, 2022 | 309,969.00 |
| Jun 30, 2022 | 327,923.00 |
| Mar 31, 2022 | 313,833.00 |
| Dec 31, 2021 | 273,724.00 |
| Sep 30, 2021 | 332,087.00 |
| Jun 30, 2021 | 491,427.00 |
| Mar 31, 2021 | 295,749.00 |
| Dec 31, 2020 | 291,615.00 |
| Sep 30, 2020 | 275,925.00 |
| Jun 30, 2020 | 244,266.00 |
| Mar 31, 2020 | 330,239.00 |
| Dec 31, 2019 | 331,507.00 |
| Sep 30, 2019 | 322,884.00 |
| Jun 30, 2019 | 411,902.00 |
| Mar 31, 2019 | 350,666.00 |
| Dec 31, 2018 | 426,351.00 |
| Sep 30, 2018 | 456,213.00 |
| Jun 30, 2018 | 301,665.00 |
| Mar 31, 2018 | 325,101.00 |
| Dec 31, 2017 | 269,816.00 |
| Sep 30, 2017 | 379,073.00 |
| Jun 30, 2017 | 307,684.00 |
| Mar 31, 2017 | 428,399.00 |
| Dec 31, 2016 | 347,445.00 |
| Sep 30, 2016 | 325,777.00 |
| Jun 30, 2016 | 379,406.00 |
| Mar 31, 2016 | 400,085.00 |
| Dec 31, 2015 | 281,202.00 |
| Sep 30, 2015 | 242,863.00 |
| Jun 30, 2015 | 286,018.00 |
| Mar 31, 2015 | 328,552.00 |
| Sep 30, 2014 | 334,339.00 |
| Jun 30, 2014 | 298,540.00 |
| Mar 31, 2014 | 358,122.00 |
| Dec 31, 2013 | 301,116.00 |
| Sep 30, 2013 | 321,630.00 |
| Jun 30, 2013 | 234,954.00 |
| Mar 31, 2013 | 231,674.00 |
| Dec 31, 2012 | 287,155.00 |
| Sep 30, 2012 | 220,121.00 |
| Jun 30, 2012 | 265,386.00 |
| Mar 31, 2012 | 432,601.00 |
| Dec 31, 2011 | 452,636.00 |
| Sep 30, 2011 | 231,278.00 |
| Jun 30, 2011 | 142,331.00 |
| Mar 31, 2011 | 145,122.00 |
| Dec 31, 2010 | 106,142.00 |
| Sep 30, 2010 | 71,205.00 |
| Jun 30, 2010 | 74,817.00 |